Vaccines and Chronic Disease |
|
|
Clinical Trial: Comparative Trial of Entecavir versus Adefovir in the Treatment of Chronic Hepatitis B Infection
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate antiviral activity and efficacy of entecavir compared to adefovir (a drug recently approved for the treatment of chronic Hepatitis b virus) in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hepatitis B Chronic Disease | Drug: entecavir Drug: adefovir | Phase III |
MedlinePlus related topics: Hepatitis B
Study Type: Interventional
Study Design: Treatment
Official Title: A Phase IIIb Comparative Trial of Entecavir versus Adefovir in the Treatment of Chronic Hepatitis B Infection
Eligibility
Ages Eligible for Study: 16 Years and above, Genders Eligible for Study: Both
Criteria
Location and Contact Information
California
Local Institution, San Francisco, California, United States; Recruiting
Local Institution, San Diego, California, United States; Recruiting
District of Columbia
Local Institution, Washington, District of Columbia, United States; Recruiting
Local Institution, Washington, District of Columbia, United States; Not yet recruiting
Florida
Local Institution, North Miami Beach, Florida, United States; Not yet recruiting
Local Institution, North Miami Beach, Florida, United States; Recruiting
Hawaii
Local Institution, Honolulu, Hawaii, United States; Recruiting
Maryland
Local Institution, Baltimore, Maryland, United States; Not yet recruiting
New York
Local Institution, New York, New York, United States; Not yet recruiting
Local Institution, Valhalla, New York, United States; Not yet recruiting
Local Institution, New York, New York, United States; Not yet recruiting
Pennsylvania
Local Institution, Philadelphia, Pennsylvania, United States; Recruiting
Texas
Local Institution, Galveston, Texas, United States; Not yet recruiting
Local Institution, Dallas, Texas, United States; Recruiting
Canada, Alberta
Local Institution, Edmonton, Alberta, Canada; Recruiting
Local Institution, Edmonton, Alberta, Canada; Not yet recruiting
Canada, British Columbia
Local Institution, Vancouver, British Columbia, Canada; Recruiting
Canada, Ontario
Local Institution, Toronto, Ontario, Canada; Recruiting
More Information
Record last reviewed: March 2005
Last Updated: March 9, 2005
Record first received: November 15, 2004
ClinicalTrials.gov Identifier: NCT00096785
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


